Jackson T. Wright

Jackson T. Wright, Mahboob Rahman, Michael C. Smith, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Michael A. Proschan, Barry R. Davis, Curt D. Furberg, 1996 .

Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline

Daniel W. Jones, Robert M. Carey, Jackson T. Wright, 2017 .

New Guideline Recommendations on Hypertension: Preventing CVD and Renal Disease with Applications to Blacks

Jackson T. Wright, G. Thornton, J. Wright, 2015 .

Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority View

Jackson T. Wright, Lawrence J. Fine, D. Lackland, 2014, Annals of Internal Medicine.

Drug treatment of hypertension in older hypertensives.

Jackson T. Wright, A. Rashidi, J. Wright, 2009, Clinics in geriatric medicine.

Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

B. Davis, Jackson T. Wright, P. Whelton, 2006, Hypertension.

Importance of Race/Ethnicity in Clinical Trials Lessons From the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Anne L. Taylor, Jackson T. Wright, J. Wright, 2005 .

Metabolic Syndrome, Components, and Cardiovascular Disease Prevalence in Chronic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study

A. Go, Jackson T. Wright, M. Joffe, 2011, American Journal of Nephrology.

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Barry R. Davis, Curt D. Furberg, Henry R. Black, 2002, JAMA.

Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study.

Jackson T. Wright, Mahboob Rahman, H. Feldman, 2015, Annals of internal medicine.

Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension

Barry J. Davis, Jackson T. Wright, P. Whelton, 2007, Diabetes Care.

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

B. Davis, Jackson T. Wright, P. Whelton, 2008, Archives of internal medicine.

APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.

Nicholette D. Palmer, Jackson T. Wright, J. Williamson, 2016, Kidney international.

ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.

B. Davis, Jackson T. Wright, P. Whelton, 2009, Archives of internal medicine.

Which drug should be used to treat patients with uncomplicated essential hypertension?

Jackson T. Wright, Mahboob Rahman, A. Rashidi, 2006, Current opinion in nephrology and hypertension.

Vitamin D and blood pressure control among hypertensive adults: results from NHANES 2001-2014.

Jackson T. Wright, A. Monaco, C. Ferri, 2019, Journal of hypertension.

Serum Bicarbonate Concentration and Cognitive Function in Hypertensive Adults.

Jackson T. Wright, Mahboob Rahman, T. Hostetter, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute.

Jackson T. Wright, P. Whelton, S. Oparil, 2008, Hypertension.

The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive Medications

B. Davis, Jackson T. Wright, P. Whelton, 2018, American journal of hypertension.

Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels.

J. Mckenney, Jackson T. Wright, M. Barnett, 1992 .

Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.

Jackson T. Wright, J. Williamson, P. Whelton, 2019, JAMA.

Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study

B. Davis, Jackson T. Wright, P. Whelton, 2012, Circulation. Cardiovascular quality and outcomes.

Thiazide-Induced Dysglycemia

Jackson T. Wright, P. Whelton, S. Oparil, 2008 .

The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.

P. Raskin, Jackson T. Wright, J. McGill, 2005, Journal of diabetes and its complications.

Oxford Handbook of Public Health Practice

D. Melzer, D. Pencheon, Jackson T. Wright, 2002 .

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Tom Greene, Lawrence J Appel, Lee Hebert, 2002, JAMA.

SPRINT Revisited: Updated Results and Implications.

Jackson T. Wright, J. Williamson, P. Whelton, 2021, Hypertension.

New recommendations for treating hypertension in black patients: evidence and/or consensus?

Anne L. Taylor, Jackson T. Wright, W. Cushman, 2010, Hypertension.

CYP3A4 and CYP3A5 Polymorphisms and Blood Pressure Response to Amlodipine among African-American Men and Women with Early Hypertensive Renal Disease

Keith C. Norris, D. O'Connor, Jackson T. Wright, 2009, American Journal of Nephrology.

Chapter 56 – Management of Hypertension in Black Populations

Jackson T. Wright, E. F. Johnson, J. Wright, 2005 .

Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.

Jackson T. Wright, R. Devereux, K. Borch-Johnsen, 2002, American heart journal.

Central Blood Pressure and Cardiovascular Outcomes in Chronic Kidney Disease.

Jackson T. Wright, Mahboob Rahman, L. Appel, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Engaging black older adults and caregivers in urban communities in health research.

Jackson T. Wright, L. Powel, P. Fulton, 2002, Journal of gerontological nursing.

The effects of weight change on glomerular filtration rate.

Jackson T. Wright, B. Astor, L. Appel, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Lowering Blood Pressure With β‐Blockers in Combination With Other Renin‐Angiotensin System Blockers in Patients With Hypertension and Type 2 Diabetes: Results From the GEMINI Trial

P. Raskin, Jackson T. Wright, J. McGill, 2007, Journal of clinical hypertension.

Determinants of Salt Sensitivity in Black and White Normotensive and Hypertensive Women

Jackson T. Wright, Mahboob Rahman, Suzanne White, 2003, Hypertension.

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. Results from the AASK trial

Jackson T. Wright, G. Bakris, T. Greene, 2003 .

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.

A. Go, Jackson T. Wright, Mahboob Rahman, 2003, Journal of the American Society of Nephrology : JASN.

Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).

A. Go, Jackson T. Wright, M. Keane, 2013, The American journal of cardiology.

Chapter 30 – The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Jackson T. Wright, S. Oparil, J. Wright, 2005 .